NEWLINK GENETICS CORP — Form D/A
NEWLINK GENETICS CORP of AMES, IA, a company, filed a Form D amendment with the SEC on 2011-09-22. The offering totals $12.8M, of which $12.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-09-22
- Form: D/A
- Accession: 0001126234-11-000006
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $12.8M
- Amount sold: $12.8M
- Investors: 38
- Date of first sale: 2010-12-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-151494
Issuer
- Name: NEWLINK GENETICS CORP
- CIK: 0001126234
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2503 SOUTH LOOP DRIVE, AMES, IA, 50010
- Phone: 515-296-5555
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Sarah J Alexander, M.D. | Director | Ames, IA |
| Paul R Edick | Director | Dublin, L2 |
| Charles Link, M.D. | Director | Ames, IA |
| David J Lundquist | Director | Ames, IA |
| Tom H Raffin, M.D. | Director | Ames, IA |
| Joseph J Saluri | Director | Ames, IA |
| Ernest H Talarico, III | Director | Ames, IA |
| Gordon H Link | Executive Officer | Ames, IA |
| Charles Link, M.D. | Executive Officer | Ames, IA |
| Kenneth J Lynn | Executive Officer | Ames, IA |
| Nicholas Vahanian, M.D. | Executive Officer | Ames, IA |
| Paul J Edick | Director | Ames, IA |
| Kenneth Lynn | Executive Officer | Ames, IA |
| Ernest Talarico, III | Director | Ames, IA |
| Tom Raffin, M.D. | Director | Ames, IA |
Other filings by this issuer (7)
More